Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
BPC-157 for gut health What the gut-repair research actually shows
Systemic copper accumulation is unlikely at standard research doses
Because the blend is copper-containing (GHK-Cu) and lacks the KPV calming component, particular caution in the research literature attaches to histamine-reactive or highly sensitive skin
US$ 25.34
US$ 25.07
US$ 22.06
US$ 27.42
US$ 21.75
US$ 22.01
US$ 27.01
